先天性副腎過形成診断市場レポート：2030年までの動向、予測、競合分析

先天性副腎過形成診断の動向と予測

世界の先天性副腎過形成診断市場は、2024年から2030年までのCAGRが7.7％で、2030年までに推定8億米ドルに達すると予測されます。この市場の主な促進要因は、先天性副腎過形成の有病率の上昇、政府の資金援助と臨床試験の増加、ヘルスケア政策と償還、遺伝子検査の技術進歩の増加です。世界の先天性副腎過形成診断市場の将来は、病院、診断センター、外来手術センター、診療所の各市場におけるビジネスチャンスによって有望視されています。

先天性副腎過形成診断市場の洞察

Lucintelは、医療従事者、患者、一般市民の間でCAHに対する認識と教育が高まっていることから、古典的な先天性副腎過形成が予測期間中に高い成長を遂げると予測しています。

病院は、優れた管理施設に容易にアクセスでき、充実したインフラの恩恵を受けられる病院ベースの治療への志向が高まっているため、最大のセグメントであり続けると思われます。

アジア太平洋地域は、多くの患者が存在すること、希少遺伝性疾患に対する意識が高まっていること、医療インフラが改善されていることから、予測期間中に最も高い成長が見込まれます。

本レポートでは、以下の11の主要な質問に回答している：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の先天性副腎過形成診断市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の先天性副腎過形成診断市場動向（2018～2023年）と予測（2024～2030年）
• タイプ別の世界の先天性副腎過形成診断市場
  • 古典的な先天性副腎過形成
  • 非古典的先天性副腎過形成
• 最終用途別の世界の先天性副腎過形成診断市場
  • 病院
  • 診断センター
  • 外来手術センター
  • クリニック
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の先天性副腎過形成診断市場
• 北米の先天性副腎過形成診断市場
• 欧州の先天性副腎過形成診断市場
• アジア太平洋の先天性副腎過形成診断市場
• その他地域先天性副腎過形成診断市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • タイプ別の世界の先天性副腎過形成診断市場の成長機会
  • 最終用途別の世界の先天性副腎過形成診断市場の成長機会
  • 地域別の世界の先天性副腎過形成診断市場の成長機会
• 世界の先天性副腎過形成診断市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の先天性副腎過形成診断市場の能力拡大
  • 世界の先天性副腎過形成診断市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Medline Industries
• Cook Medical
• Cooper Surgical
• Smiths Medical
• Becton, Dickinson and Company
• Rocket Medical
• CENTOGENE N.V
• Eurofins Scientific
• PerkinElmer
• F. Hoffmann-La Roche.

Congenital Adrenal Hyperplasia Diagnosis Trends and Forecast

The future of the global congenital adrenal hyperplasia diagnosis market looks promising with opportunities in the hospital, diagnostic center, ambulatory surgical center, and clinic markets. The global congenital adrenal hyperplasia diagnosis market is expected to reach an estimated $0.8 billion by 2030 with a CAGR of 7.7% from 2024 to 2030. The major drivers for this market are rising prevalence of congenital adrenal hyperplasia, growing government funding and clinical trials, and healthcare policies and reimbursement and increasing technological advancements in genetic testing.

A more than 150-page report is developed to help in your business decisions.

Congenital Adrenal Hyperplasia Diagnosis by Segment

The study includes a forecast for the global congenital adrenal hyperplasia diagnosis by type, end use, and region.

Congenital Adrenal Hyperplasia Diagnosis Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Classic Congenital Adrenal Hyperplasia
• Non-classic Congenital Adrenal Hyperplasia

Congenital Adrenal Hyperplasia Diagnosis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers
• Clinics
• Others

Congenital Adrenal Hyperplasia Diagnosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Congenital Adrenal Hyperplasia Diagnosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies congenital adrenal hyperplasia diagnosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the congenital adrenal hyperplasia diagnosis companies profiled in this report include-

• Medline Industries
• Cook Medical
• Cooper Surgical
• Smiths Medical
• Becton, Dickinson And Company
• Rocket Medical
• Centogene N.V
• Eurofins Scientific
• Perkinelmer
• F. Hoffmann-La Roche.

Congenital Adrenal Hyperplasia Diagnosis Market Insights

Lucintel forecasts that classic congenital adrenal hyperplasia is expected to witness higher growth over the forecast period due to growing awarness and education towards CAH among medical professionals, patients, and general public.

Hospitals will remain the largest segment due to increasing inclination towards hospital-based treatments, where they can easily access superior management facilities and benefit from enhanced infrastructure.

APAC is expected to witness highest growth over the forecast period due to presence of large pool of patients, increasing awareness towards rare genetic disorders, and improving healthcare infrastructure in the region.

Features of the Global Congenital Adrenal Hyperplasia Diagnosis Market

Market Size Estimates: Congenital adrenal hyperplasia diagnosis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Congenital adrenal hyperplasia diagnosis market size by type, end use, and region. in terms of value ($B).

Regional Analysis: Congenital adrenal hyperplasia diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and region.s for the congenital adrenal hyperplasia diagnosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the congenital adrenal hyperplasia diagnosis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the congenital adrenal hyperplasia diagnosis market size?

Answer: The global congenital adrenal hyperplasia diagnosis market is expected to reach an estimated $0.8 billion by 2030.

Q.2. What is the growth forecast for congenital adrenal hyperplasia diagnosis market?

Answer: The global congenital adrenal hyperplasia diagnosis market is expected to grow with a CAGR of 7.7% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the congenital adrenal hyperplasia diagnosis market?

Answer: The major drivers for this market are rising prevalence of congenital adrenal hyperplasia, growing government funding and clinical trials, and healthcare policies and reimbursement and increasing technological advancements in genetic testing.

Q.4. What are the major segments for congenital adrenal hyperplasia diagnosis market?

Answer: future of the global congenital adrenal hyperplasia diagnosis market looks promising with opportunities in the hospital, diagnostic center, ambulatory surgical center, and clinic markets.

Q.5. Who are the key congenital adrenal hyperplasia diagnosis market companies?

Answer: Some of the key congenital adrenal hyperplasia diagnosis companies are as follows:

• Medline Industries
• Cook Medical
• Cooper Surgical
• Smiths Medical
• Becton, Dickinson and Company
• Rocket Medical
• CENTOGENE N.V
• Eurofins Scientific
• PerkinElmer
• F. Hoffmann-La Roche.

Q.6. Which congenital adrenal hyperplasia diagnosis market segment will be the largest in future?

Answer: Lucintel forecasts that classic congenital adrenal hyperplasia is expected to witness higher growth over the forecast period due to growing awarness and education towards CAH among medical professionals, patients, and general public.

Q.7. In congenital adrenal hyperplasia diagnosis market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to substantial patient population, the increasing incidence of congenital adrenal hyperplasia, well-established hospitals and health care infrastructure, and robust governmental backing for R&D initiatives. APAC is expected to witness highest growth over the forecast period due to presence of large pool of patients, increasing awareness towards rare genetic disorders, and improving healthcare infrastructure in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the congenital adrenal hyperplasia diagnosis market by type (classic congenital adrenal hyperplasia and non-classic congenital adrenal hyperplasia), end use (hospitals, diagnostic centers, ambulatory surgical centers, clinics, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Congenital Adrenal Hyperplasia Diagnosis Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Congenital Adrenal Hyperplasia Diagnosis Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Congenital Adrenal Hyperplasia Diagnosis Market by Type
  • 3.3.1: Classic Congenital Adrenal Hyperplasia
  • 3.3.2: Non-classic Congenital Adrenal Hyperplasia
• 3.4: Global Congenital Adrenal Hyperplasia Diagnosis Market by End Use
  • 3.4.1: Hospitals
  • 3.4.2: Diagnostic Centers
  • 3.4.3: Ambulatory Surgical Centers
  • 3.4.4: Clinics
  • 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Congenital Adrenal Hyperplasia Diagnosis Market by Region
• 4.2: North American Congenital Adrenal Hyperplasia Diagnosis Market
  • 4.2.2: North American Congenital Adrenal Hyperplasia Diagnosis Market by End Use: Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Clinics, and Others
• 4.3: European Congenital Adrenal Hyperplasia Diagnosis Market
  • 4.3.1: European Congenital Adrenal Hyperplasia Diagnosis Market by Type: Classic Congenital Adrenal Hyperplasia and Non-classic Congenital Adrenal Hyperplasia
  • 4.3.2: European Congenital Adrenal Hyperplasia Diagnosis Market by End Use: Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Clinics, and Others
• 4.4: APAC Congenital Adrenal Hyperplasia Diagnosis Market
  • 4.4.1: APAC Congenital Adrenal Hyperplasia Diagnosis Market by Type: Classic Congenital Adrenal Hyperplasia and Non-classic Congenital Adrenal Hyperplasia
  • 4.4.2: APAC Congenital Adrenal Hyperplasia Diagnosis Market by End Use: Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Clinics, and Others
• 4.5: ROW Congenital Adrenal Hyperplasia Diagnosis Market
  • 4.5.1: ROW Congenital Adrenal Hyperplasia Diagnosis Market by Type : Classic Congenital Adrenal Hyperplasia, and Non-classic Congenital Adrenal Hyperplasia
  • 4.5.2: ROW Congenital Adrenal Hyperplasia Diagnosis Market by End Use: Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Congenital Adrenal Hyperplasia Diagnosis Market by Type
  • 6.1.2: Growth Opportunities for the Global Congenital Adrenal Hyperplasia Diagnosis Market by End Use
  • 6.1.3: Growth Opportunities for the Global Congenital Adrenal Hyperplasia Diagnosis Market by Region
• 6.2: Emerging Trends in the Global Congenital Adrenal Hyperplasia Diagnosis Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Congenital Adrenal Hyperplasia Diagnosis Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Congenital Adrenal Hyperplasia Diagnosis Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Medline Industries
• 7.2: Cook Medical
• 7.3: Cooper Surgical
• 7.4: Smiths Medical
• 7.5: Becton, Dickinson and Company
• 7.6: Rocket Medical
• 7.7: CENTOGENE N.V
• 7.8: Eurofins Scientific
• 7.9: PerkinElmer
• 7.10: F. Hoffmann-La Roche.